glp-1 and sarcopenia Receptor Agonists as Treatments for Type 2 Diabetes Obesity pharmacotherapy in older adults:
Description
Erratum in: Lancet 1999 Aug 14;354:602 Uthman L, Baartscheer A, Bleijlevens B, Schumacher CA, Fiolet JWT, Koeman A et al (2018) Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation
This breakthrough kicked off an arms race
6) DPP4 OR DPP-4 OR DPP-IV
They are designed to mimic the GLP-1 hormone, which plays a role in regulating blood sugar levels and appetite
Mar 1, 2024
